Last week, the Senate HELP and House Energy and Commerce Committees released a discussion draft of a plan to renew talks regarding the establishment of a nationwide "track and trace" program to help address quality and supply problems associated with the country's pharmaceutical distribution system, with indications that Members intend to press forward with legislation by the end of the year. While track and trace policies were considered over the summer prior to the enactment of legislation to reauthorize FDA's user fee program, discussions were shelved after negotiators failed to reach agreement on a number of controversial issues, including national pharmaceutical wholesaler licensing standards and whether pharmacists would be required to verify and keep records of the pedigree of each filled prescription. Committee staff are accepting written comments on the draft language until 6 p.m. on Nov. 7